Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
143.88
-0.20 (-0.14%)
At close: Feb 26, 2026
142.10%
Market Cap 3.27B
Revenue (ttm) 1.61B
Net Income (ttm) 517.39M
Shares Out 22.75M
EPS (ttm) 22.74
PE Ratio 6.33
Forward PE n/a
Dividend 13.19 (9.17%)
Ex-Dividend Date Oct 27, 2025
Volume 410,989
Average Volume 418,489
Open 144.08
Previous Close 144.08
Day's Range 142.55 - 147.25
52-Week Range 59.01 - 232.95
Beta -0.02
RSI 43.25
Earnings Date Feb 10, 2026

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, central nervous system, dermatological, cardiovascular diseases, vitamins and minerals, analgesics and antipyretics, respiratory system, and gastrointestinal and metabolic disorders. It also provides products for anthelmintic, anti-hypertensi... [Read more]

Industry Pharmaceutical Preparations
Founded 1940
Employees 144
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MPCI
Full Company Profile

Financial Performance

In fiscal year 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.

Financial Statements

News

There is no news available yet.